Studies on alpha-synuclein and islet amyloid polypeptide interaction

Ye Wang; Joakim Bergström; Martin Ingelsson; Gunilla T Westermark

doi:10.3389/fmolb.2023.1080112

Studies on alpha-synuclein and islet amyloid polypeptide interaction

Front Mol Biosci. 2023 Jan 30:10:1080112. doi: 10.3389/fmolb.2023.1080112. eCollection 2023.

Authors

Ye Wang¹, Joakim Bergström², Martin Ingelsson^{2

3

4}, Gunilla T Westermark¹

Affiliations

¹ Departments of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
² Departments ofPublic Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
³ Krembil Brain Institute, University Health Network, Toronto, ON, Canada.
⁴ Department of Medicine and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.

Abstract

Introduction: Parkinson's disease and type 2 diabetes have both elements of local amyloid depositions in their pathogenesis. In Parkinson's disease, alpha-synuclein (aSyn) forms insoluble Lewy bodies and Lewy neurites in brain neurons, and in type 2 diabetes, islet amyloid polypeptide (IAPP) comprises the amyloid in the islets of Langerhans. In this study, we assessed the interaction between aSyn and IAPP in human pancreatic tissues, both ex vivo and in vitro. Material and Methods: The antibody-based detection techniques, proximity ligation assay (PLA), and immuno-TEM were used for co-localization studies. Bifluorescence complementation (BiFC) was used for interaction studies between IAPP and aSyn in HEK 293 cells. The Thioflavin T assay was used for studies of cross-seeding between IAPP and aSyn. ASyn was downregulated with siRNA, and insulin secretion was monitored using TIRF microscopy. Results: We demonstrate intracellular co-localization of aSyn with IAPP, while aSyn is absent in the extracellular amyloid deposits. ASyn reactivity is present in the secretory granules of β-cells and some α-cells in human islets. The BiFC-expression of aSyn/aSyn and IAPP/IAPP in HEK293 cells resulted in 29.3% and 19.7% fluorescent cells, respectively, while aSyn/IAPP co-expression resulted in ∼10% fluorescent cells. Preformed aSyn fibrils seeded IAPP fibril formation in vitro, but adding preformed IAPP seeds to aSyn did not change aSyn fibrillation. In addition, mixing monomeric aSyn with monomeric IAPP did not affect IAPP fibril formation. Finally, the knockdown of endogenous aSyn did not affect β cell function or viability, nor did overexpression of aSyn affect β cell viability. Discussion: Despite the proximity of aSyn and IAPP in β-cells and the detected capacity of preformed aSyn fibrils to seed IAPP in vitro, it is still an open question if an interaction between the two molecules is of pathogenic significance for type 2 diabetes.

Keywords: BiFC; alpha-synuclein; amyloid; cross-seeding; islet amyloid polypeptide.

Grants and funding

Novo-Nordisk Foundation GW the Family Ernfors Fund GW The Swedish Diabetes association GW The Swedish Research Fund GW The Swedish Alzheimers Fund.